Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season, thinx logo

Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., announced the launch of Time To GoTM today, a multi-channel educational camp

2022 Annual Conference - Association for the Bladder Exstrophy Community

Welcome to Urovant Sciences Medical Affairs

How to Build Your Multi-Jurisdictional Telemedicine Company in the US — Nixon Gwilt Law

AI helps Stanford researchers show link between first opioid Rx and dependency

Overactive Bladder - University Urology Associates

2024 Showcase Presenters - American Urological Association

UROX - Unique Patented Formula For Bladder Tone and Control - 1 Month : : Health & Personal Care

Urovant Sciences and Thinx Inc. Help Americans with Overactive Bladders This Travel Season

Sumitovant's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile

About Us Battle River Treaty 6 Health Centre

Myovant Sciences to Host Fourth Fiscal Quarter and Fiscal Year 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on May 10, 2022

UTSW-led study shows promise for drug to treat upper urinary tract cancers : Newsroom - UT Southwestern, Dallas, Texas

Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season